Mid-day break… with EZ Wealth – September 21, 2021

[vc_row][vc_column][vc_column_text]

Mid-day break… with EZ Wealth – September 21, 2021

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_single_image image=”67679″ img_size=”large” alignment=”center”][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]Nestle India increases prices by 1-3% as commodity costs rise

Nestle India Ltd. increased prices across its product portfolio by 1-3% as commodities like milk and coffee continue to turn costlier. “Because of the global context of raw materials and also because of large economies globally are opening up strongly, there would be pressures on raw materials going forward,” Suresh Narayanan, chairman and managing director at Nestle India, said at a press conference. “The forward pressures are likely to be more acute than what we have been through at the moment.” Globally, costs of commodities like coffee, milk and packaging have seen a 4-5% uptick, he said. That came as demand rose with economies opening up after vaccination picked up pace. The maker of Maggi instant noodles saw rural growth outpace urban consumption for a few quarters.

 

DHFL creditors all set to get paid, finally

Financial creditors to Dewan Housing Finance Corp. are set to get paid over the next few days, as the insolvency process comes to a close. On Monday, creditors led by State Bank of India signed a debenture transfer agreement with Piramal Group, three people in the know confirmed. These agreements will allow lenders to take over debentures issued by Piramal Group against DHFL’s loans. After this, Piramal Group will pay the Rs 12,700-crore upfront cash consideration, out of its Rs 38,000 crore bid for DHFL. After this transaction is completed, Piramal Group can fully take over the assets and businesses of DHFL, under the Insolvency & Bankruptcy Code. Piramal Group had originally won the bid for DHFL in January this year after a majority of the creditors voted for its bid over competitor Oaktree Capital

 

Indian Pharma Market grew double digit In August

The Indian pharmaceutical market grew last month, led by demand for therapies of multiple ailments at a time when infections owing to the Covid-19 pandemic fell. Data from All Indian Origin Chemists and Distributors Ltd. pegged growth at 17.7% year-on-year in August—compared with a 13.7% rise in July and a contraction of 2.2% in August 2020. Low spread of Covid-19 wave 3 will augur well for the Indian pharma market to maintain healthy growth of its core portfolio in second half of FY22

 

HDFC announces home loans at 6.7% as festive offer

Under  this  special  offer,  customers  can  avail HDFC Home Loan starting at  6.70 percent effective 20th September 2021. This offer will be applicable to all new loan applications irrespective of the loan amount or employment category. The special rate is linked to the borrower’s credit score. This is a close-ended scheme and will be valid till 31st October 2021

 

SpiceJet gets shareholders’ nod to transfer logistics business on slump sale basis to subsidiary

shareholders have approved the transfer of its cargo and logistics services business to a subsidiary, on a slump sale basis, through an all-share deal worth over Rs 2,555 crore, a move that will help the airline to significantly reduce its negative networth. Besides, the shareholders have cleared the proposal to raise up to Rs 2,500 crore through the Qualified institutional placement (QIP) route.[/vc_column_text][vc_column_text]

Disclosure:
EZ Wealth is a Stock Broker registered with BSE, NSE and MSEI in all the major segments viz. Cash, F&O and CDS segments. EZ Wealth is also a Depository Participant and registered with both the Depositories viz. CDSL and NSDL. Further, EZ Wealth is a SEBI registered Portfolio Manager. EZ Wealth is a step-down subsidiary of Wealth Discovery Securities Pvt. Ltd (referred as ‘WDSPL’ hereafter).
This report is not to be altered, transmitted, reproduced, copied, redistributed, uploaded, published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from EZ Wealth.
The projections and the forecasts described in this report are based on estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections are forecasts were based may not materialize or may vary significantly from actual results and such variations will likely increase over the period of time. The recipients should consider and independently evaluate whether it is suitable for its/ his/ her/their particular circumstances and if necessary, seek professional / financial advice as there is substantial risk of loss. EZ Wealth does not take any responsibility thereof. Any such recipient shall be responsible for conducting his/her/its/their own investigation and analysis of the information contained or referred to in this report and of evaluating the merits and risks involved in securities forming the subject matter of this report. The price and value of the investment referred to in this report and income from them may go up as well as down, and investors may realize profit/loss
This report has been prepared by EZ Wealth and published in accordance with the provisions of Regulation 19 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, for use by the recipient as information only and is not for general circulation or public distribution. The solicitation of an offer to buy, purchase or subscribe to any securities, and neither this report nor anything contained therein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. It does not constitute a personal recommendation or take into account the particular investment objective, financial situation or needs of any individual in particular. The research analysts of EZ Wealth have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. The recipients of this report must make their own investment decisions, based on their own investment objectives, financial situation or needs and other factors. Past performance is not a guide for future performance. Actual results may differ materially from those set forth in the projection. This report has been prepared by EZ Wealth based on the information available in the public domain and other public sources believed to be reliable. Though utmost care has been taken to ensure its accuracy and completeness, no representation or warranty, express or implied is made by EZ Wealth that such information is accurate or complete and/or is independently verified.
The contents of this report represent the assumptions and projections of EZ Wealth and EZ Wealth does not guarantee the accuracy or reliability of any projection, assurances or advice made herein. Nothing in this report constitutes investment, legal, accounting and/or tax advice or representation that any investment or strategy is suitable or appropriate to recipients’ specific circumstances. Since EZ Wealth or its associates are engaged in various financial activities, they might have financial interest or beneficial ownership in various companies including subject company/companies mentioned in the report. EZ Wealth or its associates have not received any compensation for investment any compensation including brokerage services and for products or services other than investment banking or merchant banking from the subject company in the past 12 months. It is confirmed that EZ Wealth or research analyst or its associates have not managed or co-managed public offering of securities for the subject company in the past 12 months.
Research analyst or EZ Wealth or its relatives’/associates’ have no material conflict of interest at the time of publication of this report. Neither research analyst nor EZ Wealth are engaged in market making activity for the subject company. It is confirmed that research analysts do not serve as an officer or director. No material disciplinary action has been taken on EZ Wealth by any regulatory authority impacting Equity Research Analysis activities. The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law, without any prior notice. EZ Wealth reserves the right to make modifications and alternations to this statement, as may be required, from time to time. Research analyst or EZ Wealth or its actual/beneficiary ownership of 1% depends from case of case. It is also confirmed that research analysts have not received any compensation from the subject company in the past 12 months.
WDSPL registered address: 1206, 12th Floor, Kailash Building K.G. Marg.
Connaught Place New Delhi-110001
Tel No: 91 +11-43444-666 | 91 +11-43444-623 |
Wealth Discovery Securities Pvt Ltd – CIN: U74999DL2010PTC211626
Wealth Discovery Commodity Pvt Ltd – CIN: U74999DL2011PTC213264
SEBI-NSE-INB/F/E231435737,BSE-INB011435733/INF011435833, DP-IN-DP-CDSL-679-2013 SEBI- REG.NO- MCX & NCDEX – INZ000015731

[/vc_column_text][/vc_column][/vc_row]

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top